You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
DHS DoD 13.2-A13-089-MaXentric Technologies LLC
SBC: MAXENTRIC TECHNOLOGIES LLC Topic: A13089DHS in support of FEMA identifies a need for a sensor system to detect potential survivors buried in rubble piles or confined spaces in the event of a building collapse. In response to the solicitation, MaXentric proposes a radar-based system capable of detecting motion through debris such as respiration and/or heart beats. The system will alert the user of a potential victim's location relative t ...
SBIR Phase II 2023 Department of Homeland SecurityScience and Technology Directorate -
P-FITS: The Pediatric Food Intake Technology System
SBC: Viocare, Inc. Topic: NICHDDiet plays an integral role in the physical, emotional, and general health of children and adolescents. The consequences of poor diet during this critical time period are long-lasting, with nutritional status being a strong risk factor for chronic conditions throughout adolescence and adulthood. Current dietary assessment tools available for self-administration in older children are extremely limi ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now
SBC: ANALYTICAL DIAGNOSTIC SOLUTIONS INC Topic: NICHDAbstractThis application is in regard to the National Center for Advancing Translational Sciences SBIR/STTR Omnibus Solicitation. In Vitro Diagnostic Solutions, LLC (IVDS) proposes to develop a point-of-care test (POCT) to rapidly determine blood creatine phosphokinase (CPK) activity for the improved management of long-chain fatty acid oxidation disorders (LCFAODs). FAODs are inborn errors of meta ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
SBC: CELDARA MEDICAL, LLC Topic: 200Project Summary According to the American Diabetes Association, Type 2 diabetes mellitus (T2D) affects at least 30 million Americans and is a major unmet public health concern with an annual cost in the United States of over $300 billion dollars. Additionally, nearly 25% of the U.S. population is already considered prediabetic, or at high risk of developing T2D. These individuals are characterized ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Non-invasively extendable megaprosthesis
SBC: Granite Medical, LLC Topic: NIAMSABSTRACT This project is the development of a non-invasively extending distal femur replacement (DFR) for children and adolescents subsequent to bone tumor resection. Each year in the US there are 200-250 malignant bone tumor diagnoses in the distal femurs of patients 15 years and younger. With advances in chemotherapy, limb salvage surgery utilizing a megaprosthesis has increasingly become the tr ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis
SBC: PROTHERA BIOLOGICS, INC. Topic: NICHDNecrotizing enterocolitis (NEC) is a devastating acute inflammatory condition of the gastrointestinal tract resulting in intestinal necrosis, systemic sepsis and multi-system organ failure found mostly in infants born prematurely. Despite modern medical advances in the past decade, the etiology remains elusive and morbidity and mortality are still unacceptably high. It has been concluded that the ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
SBC: CELDARA MEDICAL, LLC Topic: 105SUMMARY Amyotrophic lateral sclerosis (ALS) patients develop fatal paralysis as a result of progressive motor neuron loss in the brain and spinal cord. There are more than 5,000 new cases of ALS per year in the United States, with typical age of onset between 40 and 70 years of age. While SOD1 is a cytoplasmic protein, misfolded SOD1 can be secreted and form extracellular oligomers and aggregates. ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: 105Perinatal brain injury resulting in mental retardation and cerebral palsy is the most severe disability in children and affects 40-148 in preterm and 1–2/1000 in full term infants. This places a huge burden on society, emphasizing the critical need for improved prevention/treatment strategies to decrease perinatal brain injury. Hypothermia (HT) is the only FDA approved therapy to attenuate brain ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Ultrasound-coupled Electrical Impedance Tomography for Sarcopenia Assessment
SBC: RYTEK MEDICAL INC Topic: NIAPROJECT SUMMARY/ABSTRACT Clinical Need: The coming decades promise a revolution in the personalized treatment for patients with breast cancer, including approaches to minimize collateral damage of curative. However, to help facilitate this, the academic and industrial clinical research communities need improved diagnostic biomarkers to assess the presence of muscle diseases such as sarcopenia. Onc ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Using Machine Learning and Blockchain Technology to Reduce Drug Diversion in Hospitals
SBC: AUTONOMOUS HEALTHCARE INC Topic: NIDABased on an analysis, the volume of dosage lost due to diversion increased from 21 million in 2017 to 47 million in 2018, a 126% increase. Addressing the drug diversion problem is a multi-faceted problem involving many components ranging from provider training to implementation of hardware and software systems to manage access to controlled substances. However, despite recent improvements in contr ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health